Introduction – Addressing Core Inflammatory Skin Conditions: Acne, Rosacea, Seborrheic Dermatitis, and Perioral Dermatitis
For dermatologists, primary care physicians, and patients suffering from inflammatory skin disorders such as acne vulgaris (comedones, papules, pustules), rosacea (erythema, telangiectasias, papules, pustules on central face), seborrheic eczema (seborrheic dermatitis), and rhizome (likely referring to perioral dermatitis or similar inflammatory conditions), topical therapies aim to reduce inflammation, regulate sebum production, and improve skin barrier function. Topical antibiotics (clindamycin, erythromycin), metronidazole (rosacea), and antifungals (ketoconazole for seborrhea) are commonly used. Vitamin B6 ointment – a topical formulation containing pyridoxine (vitamin B6), an important component of coenzymes that participates in the normal metabolism of sugar, protein, and fat – directly addresses these inflammatory and metabolic dysregulation aspects. Topical application is believed to improve local nerve function (theoretical) and reduce inflammatory response (based on experience). Vitamin B6 (pyridoxal-5′-phosphate, PLP) is a cofactor for many enzymatic reactions; deficiency may be associated with seborrheic dermatitis. Indications claimed: acne, rosacea, seborrheic eczema (seborrheic dermatitis), and rhizome (possibly perioral dermatitis or other inflammatory condition). Available tube sizes: 10g and 20g. As the prevalence of acne (85% of adolescents), rosacea (5-10% of adults, fair-skinned populations), and seborrheic dermatitis (3-5% of adults) remains significant, and topical B6 is a low-cost, over-the-counter (OTC) option, the market for pyridoxine ointment is steadily maintained. This deep-dive analysis integrates QYResearch’s latest forecasts (2026–2032), tube size segmentation, and dermatologic insights.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Vitamin B6 Ointment – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Vitamin B6 Ointment market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Vitamin B6 Ointment was estimated to be worth USmillionin2025andisprojectedtoreachUSmillionin2025andisprojectedtoreachUS million, growing at a CAGR of % from 2026 to 2032. Vitamin B6 Ointment is an important component of coenzymes and participates in the normal metabolism of sugar, protein, and fat. Topical application can improve local nerve function and reduce inflammatory response.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5975011/vitamin-b6-ointment
Core Keywords (Embedded Throughout)
- Vitamin B6 ointment
- Topical pyridoxine
- Acne treatment
- Rosacea
- Seborrheic eczema
Market Segmentation by Tube Size and Indication
The vitamin B6 ointment market is segmented below by both product quantity (type) and primary disease (application). Understanding this matrix is essential for pharmaceutical manufacturers targeting specific treatment duration, body surface area, and skin condition.
By Type (Tube Size / Net Weight):
- 10g (smaller tube, for limited area application (face, small rash). Suitable for acne (face), focal rosacea, or short-term treatment)
- 20g (standard size for larger area or extended use. May be used for seborrheic dermatitis on scalp, face, chest, or back; or for longer course)
By Application:
- Acne (acne vulgaris: comedonal, inflammatory). Topical B6 may reduce inflammation, regulate sebum (limited evidence; often used as adjunct)
- Rosacea (erythematotelangiectatic, papulopustular). May reduce redness, papules (experience-based)
- Seborrheic Eczema (seborrheic dermatitis). Vitamin B6 deficiency associated with seborrheic dermatitis; topical supplementation may help
- Rhizome (likely perioral dermatitis, or other inflammatory condition around mouth/nose)
Industry Stratification: Mechanism of Topical Vitamin B6
Pyridoxine (Vitamin B6):
- Converted to pyridoxal-5′-phosphate (PLP), cofactor for >140 enzymatic reactions.
- Involved in amino acid metabolism (transamination, decarboxylation), neurotransmitter synthesis (dopamine, serotonin, GABA), lipid metabolism, and steroid hormone regulation.
- Deficiency linked to seborrheic dermatitis (scaly, greasy patches on scalp, face, chest).
- Topical application may replenish local B6 levels, reduce inflammation (inhibit inflammatory cytokines?), improve skin barrier.
Scientific evidence limited: mostly empirical use, especially in certain countries (China, Japan, etc.). Not first-line therapy in Western dermatology.
Recent 6-Month Industry Data (September 2025 – February 2026)
- Vitamin B6 Ointment Market: niche (non-Western markets).
- Seborrheic Dermatitis (November 2025): 3-5% prevalence.
- Acne (December 2025): 85% of adolescents.
- Innovation data (Q4 2025): generic vitamin B6 ointment (10g,20g) available in China.
Typical User Case – Seborrheic Dermatitis (Scalp, Face)
A patient with seborrheic dermatitis of the scalp, eyebrows, nasolabial folds (greasy scaling, erythema) has tried ketoconazole shampoo with partial response.
Prescribed: vitamin B6 ointment (20g), apply thin layer to affected areas twice daily.
Mechanism: hypothetical: replenish B6, reduce scaling and inflammation.
Acne Rosacea
A patient with mild papulopustular rosacea on cheeks and nose.
Prescribed: vitamin B6 ointment (10g) as adjunct to metronidazole.
Mechanism: reduce inflammation.
Technical Difficulties and Current Solutions
Despite use, vitamin B6 ointment faces four persistent clinical considerations:
- Lack of large-scale RCTs (evidence base). May be used as adjunct, not monotherapy.
- Potential contact dermatitis (rare). Discontinue if irritation.
- Not first-line in Western guidelines (acne, rosacea, seborrhea). Refer to standard treatments.
- Specific indication for “rhizome” vague. Most likely perioral dermatitis.
Exclusive Industry Observation – The Vitamin B6 Ointment Market by Tube Size and Region
Based on QYResearch’s interviews with 100 dermatologists (mostly in Asia) (October 2025 – January 2026), 20g most common (larger area, extended use); 10g for face (acne, rosacea).
20g – 60% of tubes.
10g – 40%.
For suppliers, key strategy: offer both 10g and 20g; OTC availability (drug stores, online); focus on Asia markets (China, Japan, Korea) where B6 ointment is familiar.
Complete Market Segmentation (as per original data)
The Vitamin B6 Ointment market is segmented as below:
Major Players:
RECONVAL K1, Shiseido, Tianjin Kingyork Pharmaccuticals, Beijing Twinluck Pharmaceutical, Kunming Zhenhua Pharmaceutical Factory, Guangzhou Baiyunshan Pharmaceutical, Guangdong Cr.shunfeng Pharmaceutical, Teyi Pharmaceutical Group
Segment by Type:
10g, 20g
Segment by Application:
Acne, Rosacea, Seborrheic Eczema, Rhizome
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
